Todd W. Garner - Mar 1, 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Executive Vice President & CFO
Signature
Sarah M. Oliker for Todd W. Garner by Power of Attorney
Stock symbol
CNMD
Transactions as of
Mar 1, 2022
Transactions value $
-$67,794
Form type
4
Date filed
3/3/2022, 05:16 PM
Previous filing
Jan 5, 2022
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +1.6K +117.39% $0.00 2.96K Mar 1, 2022 Direct
transaction CNMD Common Stock Tax liability -$67.8K -469 -15.83% $144.55 2.49K Mar 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -1.6K -50% $0.00 1.6K Mar 1, 2022 Common Stock 1.6K $0.00 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +55K $0.00 55K Mar 1, 2022 Common Stock 55K $144.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F2 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period